Powered by our PhasED-Seq technology, Foresight CLARITY™ is a highly sensitive minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.
Jun 06, 2024
icon-download Download Poster
May 29, 2024
May 01, 2024